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Available online 25 August 2010Antigen-speciﬁc proliferation is a critical function of memory T cells that is often utilised to
measure vaccine immunogenicity and T cell function. We proposed that measurement of
intracellular expression of the nuclear protein, Ki67, could reliably assess speciﬁc T cell
proliferation in vitro.
Ki67 was expressed in CD4+ and CD8+ T cells that had undergone in vitro proliferation after
6-day culture of human whole blood or PBMC with antigens. T cells cultured with no antigen
did not express Ki67. When compared to current ﬂow cytometry based proliferation assays,
Ki67 detected proliferating cells with greater sensitivity than BrdU incorporation, whereas its
sensitivity was similar to dye dilution of Oregon Green (OG), a CFSE derivative. Overall, the
magnitude and cytokine expression proﬁle of proliferating T cells detected by Ki67 expression
correlated strongly with T cells detected with BrdU or OG. The intra-assay variability of Ki67
proliferation was 2–3% for CD4+ T cells, and 10–16% for CD8+ T cells. Finally, we demonstrate
that the Ki67 assay detects tetanus toxoid-speciﬁc CD4+ T cell proliferation after infant
vaccination with tetanus toxoid (TT).
Overall our data suggest that intracellular Ki67 expression provides a speciﬁc, quantitative and
reproducible measure of antigen-speciﬁc T cell proliferation in vitro.
© 2010 Elsevier B.V. Open access under CC BY license. Keywords:
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Clinical immunology1. Introduction
Proliferation and clonal expansion of antigen-speciﬁc T cells
are critical functions for mediating protective immunity and
immunological memory (Rosenberg et al., 1997; Combadiere
et al., 2004). Previously, the most widely used method forT, tetanus toxoid; OG,
n, Faculty of Health
rn Cape, South Africa.
Hanekom).
equally to this manu-
Y license. detection of antigen-speciﬁc T cell proliferation has involved
incorporation of 3H-thymidine into DNA of dividing cells
(Payan et al., 1983; Marchant et al., 1999). This technique has
largely been replaced by ﬂow cytometric assays of prolifera-
tion. Examples include ﬂuorescent dye dilution assays, using
CFSE or its derivative, Oregon Green (OG) (Magg and Albert
2007; Wallace et al., 2008; MacMillan et al., 2009), and assays
that detect the DNA intercalating agent, 5-bromo-2′-deoxyur-
idine (BrdU), detected by ﬂuorochrome-conjugated antibody
staining (Dolbeare et al., 1983; Houck and Loken 1985; Rosato
et al., 2001). The advantages of these assays are that they allow
co-stainingwith othermarkers, enabling delineation of cellular
sub-populations according to phenotype and functional char-
acteristics, such as cytokine production (Lyons, 2000; Bach-
mann et al., 2005; Precopio et al., 2007).
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of cell division. This marker has been used extensively in
cancer biology to indicate tumour cell proliferation (Gerdes,
1990; Scholzen and Gerdes, 2000). The protein is expressed
during all active phases of cell division, but is absent in
quiescent cells and during DNA repair (Gerdes et al., 1984).
Intracellular Ki67 expression directly ex vivo, or after in vitro
cell culture, has been used to measure speciﬁc T cell
responses induced by vaccination (Stubbe et al., 2006;
Cellerai et al., 2007; Miller et al., 2008), or turnover of these
cells in individuals with chronic viral infections, such as HIV
infection (Sachsenberg et al., 1998; Doisne et al., 2004).
In this study, we show that Ki67 expression in T cells is a
speciﬁc and quantitative indicator of proliferation, and that
results are comparable to those when proliferation is
measured by other methods. We also show that measure-
ment of Ki67 may be applied to longitudinal monitoring of
vaccine-speciﬁc T cell responses. Overall, the Ki67 assay offers
a reliable, versatile and simple method for detection of
antigen-speciﬁc T cell proliferation.
2. Materials and methods
2.1. Study subjects
Healthy adult donors were recruited at the Institute of
Infectious Disease and Molecular Medicine, University of
Cape Town. Healthy, 18 month old toddlers were recruited at
the South African Tuberculosis Vaccine Initiative clinic sites in
the Western Cape, South Africa, before, and 11–13 days after
their routine 18 month vaccination with TT. Enrolled toddlers
had received all routine childhood vaccinations as set out by
the WHO Expanded Programme on Immunisation. Hepar-
inised venous blood from adults and toddlers was collected
into BD Vacutainer CPT tubes (BD Biosciences) and immedi-
ately processed as outlined below. Participation of all
participants was in accordance with the Declaration of
Helsinki, the US Department of Health and Human Services
guidelines, and good clinical practice guidelines. This includ-
ed protocol approval by the Research Ethics Committee of the
University of Cape Town, and written informed consent by all
adults or parents of the toddlers.
2.2. Whole blood BrdU incorporation assay
Whole blood (125 μL diluted 1:10 in warm RPMI 1640)
was incubated with antigens for 6 days at 37 °C with 5% CO2.
Antigens were used at the following ﬁnal concentrations:
1×105 cfu/mL Danish BCG (Danish strain 1331; Statens
Serum Institut), 1 μg/mL TB10.4 protein (kindly provided
by Tom Ottenhoff, Leiden University, Leiden, Netherlands),
2 μg/mL M. tuberculosis puriﬁed protein derivative (PPD,
Statens Serum Institut) and 0.16 IU TT (Tetavax, Sanoﬁ
Pasteur). On day 6 (day 3 for PHA), 10 μmol/L BrdU (Sigma-
Aldrich) was added for the last 5 h of culture. When
intracellular cytokine expression was assessed, 10 ng/mL
phorbol 12-myristate 13-acetate (PMA, Sigma-Aldrich),
1.5 μg/mL ionomycin (Sigma-Aldrich) and 1.5 μg/mL Brefel-
din A (Sigma-Aldrich) were also added during the last 5 h of
culture. Control antigens included 1 μg/mL phytohaemagglu-
tinin (PHA; positive control, Sigma-Aldrich), medium only(unstim., negative control) or, for intracellular cytokine
assays, medium with PMA and ionomycin (unstim-PI). On
day 6, cells were harvested with 2 mM EDTA (Sigma-Aldrich)
and red blood cells lysed. White cells were stained with a
viability dye (LIVE/DEAD Fixable Violet Dead Cell Stain Kit,
Invitrogen), ﬁxed in BD FACS Lysing Solution (BD Bios-
ciences) according to manufacturer's instructions and cryo-
preserved until analysis.
2.3. PBMC isolation and the OG assay
PBMC were isolated by density gradient centrifugation
and immediately stained with 10 μg/mL of CellTrace Oregon
Green 488 (Molecular Probes, Invitrogen) per 1×107
cells and rested overnight at 37 °C, 5% CO2. Cells were
either incubated with medium or 1×105 cfu/mL Danish
BCG, 0.5 μg/mL PPD, 1 μg/mL TB10.4 protein or 0.05 μg/mL
staphylococcal enterotoxin B (SEB, positive control, Sigma-
Aldrich), for 6 days at 37 °C with 5% CO2. On day 6 for
some assays, PBMC were restimulated with 50 ng/mL PMA,
250 ng/mL ionomycin and 10 μg/mL Brefeldin A for a further
5 h. Finally, PBMC were stained with LIVE/DEAD Fixable
Violet Dead Cell Stain, ﬁxed with BD FACS Lysing Solution (BD
Biosciences) and cryopreserved until analysis.
2.4. Antibodies and ﬂow cytometry
The following monoclonal antibodies were used for
phenotypic and/or intracellular cytokine staining: CD3-QDot
605 (UCHT1), CD4-PerCP (SK3), CD8-PerCP-Cy5.5 (SK1), Ki67-
PE (B56), IFN-γ-Alexa Fluor 700 (B27), TNF-α-PE-Cy7
(MAb11), IL-2-APC (MQ1-17H12), and anti-BrdU-FITC (B44).
All antibodies were from BD Biosciences except for CD3-QDot
605, which was from Invitrogen. Samples were acquired on a
BD LSRII ﬂow cytometer (BD Biosciences, San Jose, CA).
2.5. Data analysis
Cell doublets were excluded using forward scatter-area
versus forward scatter-height parameters. Single-stained or
unstained mouse κ beads were used to calculate compensa-
tions for every run. In some experiments CD4+ T cells were
gated as CD3+ CD8− lymphocytes, because PMA and
ionomycin stimulation strongly down-regulates CD4 expres-
sion on T cells. Data were analysed with FlowJo software
v.8.8.6 (Treestar Inc.), Pestle v 1.6.2 and Spice v 4.3.2 software
(provided by M. Roederer, National Institutes of Health,
Bethesda, MD). Statistical analyses were calculated using
GraphPad Prism v 4.0.
3. Results
3.1. Ki67 is a speciﬁc marker of in vitro lymphoproliferation
Ki67 is expressed by all cells undergoing cycling (Lopez
et al., 1991; Scholzen and Gerdes, 2000). We investigated the
kinetics of Ki67 expression in T cells cultured over 6 days.
Whole blood was either cultured in the absence of antigen
(unstimulated), or in the presence of puriﬁed protein
derivative (PPD) or anti-CD3 and anti-CD28 (αCD3/αCD28).
Expression of Ki67 was quantiﬁed each day. Ki67 expression
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0.62%), and by day 6, had decreased to b0.1% of CD4+ T cells
(median, 0.08%, Fig. 1A). PPD stimulation resulted in Ki67
expression levels above those in unstimulated cells between
days 2 and 4; expression peaked on day 6 (Fig. 1A and B). High
expression of Ki67 was observed following polyclonal T cell
stimulation with αCD3/αCD28; Ki67 was observed responses
were high on day 1 already, peaked on day 3, and declined
thereafter (Fig. 1A and C).
Next, we assessed proliferation by Ki67 detection in whole
blood from 15 healthy donors, after 6-day culture with noFig. 1. Ki67 as a speciﬁc marker of in vitro lymphoproliferation. Whole blood from he
quantiﬁed on a daily basis over 6 days. (A) Representative example showing the fre
with medium only (unstim.), PPD or αCD3/αCD28 over 6 days. Dotplots were gat
(B) PPD stimulation or (C) αCD3/αCD28 stimulation in 4 donors. Data are expressed
cells is indicated in each plot. (D) Frequencies of Ki67 expressing CD4+ T cells in wh
PPD. (E) Frequencies of Ki67+ CD4+ T cells in PBMC from 14 donors. Differences wantigen, or with PPD. All donors had undetectable or very low
frequencies of Ki67+ CD4+ T cells in unstimulated blood
(median, 0.07%). PPD stimulation resulted in higher frequen-
cies of Ki67+ CD4+ T cells in all donors (median, 46.1%,
Fig. 1D).
We also determined whether proliferation could be
detected by assessing Ki67 expression in PBMC. Again, Ki67
expression identiﬁed in vitro CD4+ T cell proliferation;
frequencies of Ki67+ cells after PPD stimulation consistently
exceeded those in unstimulated PBMC, at a median of 21.7%
(Fig. 1E).althy donors was incubated with the indicated antigens and Ki67 expression
quencies of Ki67 expression by CD4+ T cells after incubation of whole blood
ed on live, CD3+ CD4+ lymphocytes. Ki67+ CD4+ T cell frequencies after
as a percentage of the maximum response. The frequency of Ki67+ CD4+ T
ole blood from 15 donors after 6-day culture with medium only (unstim.) or
ere calculated using the Wilcoxon matched pairs test.
Fig. 2. Comparison of the Ki67 proliferation assay with the BrdU and Oregon
Green proliferation assays. (A) Representative dotplots showing Ki67
versus BrdU expression by CD4+ T cells in whole blood. Dotplots are gated
on live, CD3+ CD8− lymphocytes. Frequencies of (B) PPD- and (C) TB10.4-
speciﬁc CD4+ T cell proliferation as detected by Ki67 expression or BrdU
incorporation (n=15). CD4+ T cells are deﬁned as CD3+ CD8− T cells (see
Data analysis). (D) Representative dotplots showing Ki67 and dye dilution o
OregonGreenbyCD4+Tcells inPBMC.Dotplots are gatedon live, CD3+CD8−
lymphocytes. Frequencies of (E) PPD- and (F) TB10.4-speciﬁc CD4+ T cel
proliferation as detected by Ki67 expression or dye dilution of Oregon Green
(OGlow) in 14 donors. CD4+T cells are deﬁned as CD3+CD8− T cells (seeData
analysis). Differences were calculated using the Wilcoxon matched pairs test.
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culture with antigen, Ki67 expression is up-regulated in T
cells undergoing in vitro proliferation.
3.2. Comparison of Ki67 expression with BrdU and Oregon
Green assays
Next, we compared our Ki67-based proliferation assay
with more traditional ﬂow cytometric proliferation assays,
i.e., those measuring BrdU incorporation and dye dilution of
OG (Fig. 2).
BrdU is incorporated into cells undergoing DNA synthesis,
and is typically added during the last 2 to 24 h of a proliferation
assay; in this study we added BrdU for the last 5 h of the 6-day
culture. The frequency of Ki67+ CD4+ T cells was higher than
the frequency of BrdU+ cells after whole blood stimulation
with PPD or TB10.4 protein (Fig. 2A, B and C). Importantly, all
BrdU+ cells co-expressed Ki67 (Fig. 2A).
The OG assay requires uniform labelling of cells prior to
long-term culture. In contrast to results from the BrdU assay,
the OG and Ki67 assays yielded remarkably similar frequen-
cies of proliferating, speciﬁc T cells; Ki67+ and OGlow CD4+ T
cell frequencies were not different in PPD or TB10.4-
stimulated PBMC (Fig. 2D, E and F).
Frequencies of Ki67+CD4+T cells correlated stronglywith
BrdU+ CD4+ T cell frequencies (Fig. 3A and B). Similarly, a
strong correlation was found between frequencies of antigen-
speciﬁc Ki67+ and OGlow CD4+ T cells (Fig. 3C and D).
These data show that frequencies of proliferating T cells
detected by Ki67 expression agree with frequencies detected
with conventional proliferation assays.
3.3. Cytokine expression proﬁles of proliferating CD4+ T cells
The functional capacity of cells that have expanded during
the 6-day culture may be assessed by short-term polyclonal
re-stimulation with PMA and ionomycin on day 6. This
induces cytokine production, which can be measured by
intracellular staining. We compared expression of IFN-γ, IL-2
and TNF-α by Ki67+ CD4+ T cells with expression of these
cytokines in BrdU+ or OGlow CD4+ T cells. When Ki67
and BrdU assay results were compared, similar expression of
IFN-γ and TNF-α was observed in proliferating CD4+ T cells.
BrdU+CD4+T cells yielded higher proportions of IL-2+ cells
than Ki67+ CD4+ T cells but these differences were small
(Fig. 4A and B). Similar expression proﬁles of IFN-γ, IL-2 and
TNF-α were observed when comparing Ki67+ and OG
dilution (Fig. 4C and D).
3.4. Intra-assay variability of Ki67 proliferation assay
To test the reproducibility of theKi67proliferation assay,we
performed 5 proliferation assays per donor on whole blood
from 3 healthy adult volunteers. Intra-assay coefﬁcient of
variation (CV) values for PPD-speciﬁcKi67+CD4+Tcellswere
between 2% and 3%, and for Ki67+ CD8+ T cells, which were
present at lower frequencies than Ki67+ CD4+ T cells,
between 10 and 16%. Even lower CV values were observed for
PHA-stimulated blood, which induced the highest frequencies
of Ki67+ T cells (Table 1). These results indicate that the Ki67
proliferation assay generates highly reproducible ﬁndings.f
l3.5. Measurement of vaccination-induced T cell proliferation
To establish if Ki67 can be used to measure vaccine-
speciﬁc T cell proliferation, we determined Ki67 expression
in T cells before and 11–13 days after tetanus toxoid (TT) re-
immunisation of healthy, 18 month old infants. This post-
vaccination time point was selected because it coincides with
the peak TT-speciﬁc CD4+ T cell response in healthy adults
(Cellerai et al., 2007).
The frequency of proliferating, Ki67+ CD4+ T cells observed
pre-vaccination, following in vitro incubation of whole blood
with TT, was low (median, 0.15%). After vaccination, TT-speciﬁc
CD4+ T cell proliferation increased markedly (median, 3.77%,
Fig. 3. Correlations between Ki67+ CD4+ T cell expression and BrdU
incorporation or dye dilution of Oregon Green (OGlow). Whole blood was
incubated with (A) PPD or (C) TB10.4 for 6 days (n=15). PBMC were
incubated with (B) PPD or (D) TB10.4 for 6 days (n=14). Correlations were
calculated using a Spearman's rank correlation coefﬁcient.
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of Ki67 after TT vaccination in vitro, we also quantiﬁed BCG-
speciﬁc T cell proliferation pre- and post-vaccination. Frequen-
ciesofBCG-speciﬁcKi67+CD4+Tcellswerenotdifferentbefore
and after TT vaccination (Fig. 5A, C and D).
It is well established that vaccination-induced T cell
proliferation results in increased in vivo and, thus, ex vivo
expression of Ki67 (Cellerai et al., 2007; Miller et al., 2008). To
determine whether “background” expression levels of Ki67,
reﬂecting in vivo T cell turnover, affected the detection of
antigen-speciﬁc T cell proliferation in vitro, we quantiﬁed
Ki67 expression directly ex vivo in whole blood from toddlers
before and 11–13 days after TT vaccination. High ex vivo
frequencies of Ki67+ CD4+ T cells were readily detected in
all toddlers before and after TT vaccination (Fig. 5E and F).
Importantly, after 6 days of culture in the absence of antigen,
Ki67 expression decreased markedly to background levels
(Fig. 5E and F).
These data suggest that in vivo T cell turnover does not
interfere with the speciﬁcity of the Ki67 proliferation assay.
This assay is therefore speciﬁc for the detection of antigen-
speciﬁc T cell proliferation in vitro.4. Discussion
Proliferation is a commonly measured indicator of T cell
function. We assessed intracellular Ki67 expression as a
marker of in vitro proliferation in whole blood or PBMC-based
assays. We show that the Ki67 assay provides an alternative
approach to measuring antigen-driven T cell proliferation,
and found that results obtained were very similar to those
generated by commonly used proliferation assay systems.The development of ﬂuorescent dyes and tracking markers
has enabled combined analysis of antigen-speciﬁc T cell
proliferation, phenotyping and cytokine expression by ﬂow
cytometry (Johannisson and Festin, 1995; Mehta and Maino,
1997; Lyons and Doherty, 2004; Wallace et al., 2008). To date,
whole blood BrdU and PBMC dye dilution assays have been the
preferred ﬂow cytometry based methods to assess lymphocyte
proliferation. In comparison, Ki67 expression identiﬁed ap-
proximately double the frequency of proliferating CD4+T cells
detected byBrdU incorporation. Incubationof cellswith BrdU is
limited to 24 h or less because incorporated BrdU inhibits cell
cycle progression. Therefore a major limitation of the BrdU
assay is that only cells that have progressed through the S-
phase during this short incubation period may be detected. In
contrast, cells express Ki67 in all active phases of the cell cycle.
Therefore, Ki67 appears to be a more sensitive marker for the
detection of rare T cell responses, and may reﬂect the extent of
in vitro antigen-speciﬁc proliferation more accurately than
BrdU incorporation.
Cellular proliferation in PBMC samples is routinely evaluat-
ed by dye dilution methods, using CFSE or derivatives such as
OG (Robinson and Amara, 2005). A recent non-human primate
studyhas proposedmeasurementof in vitroproliferationby the
combined analysis of Ki67 and side scatter properties of cells
(Shedlock et al., 2010). The authors demonstrate a correlation
between this assay and theCFSE dilution assay. In this study,we
show that the proliferation events detected by loss of OG dye
are virtually identical to the Ki67+ events. From this we
reasoned that Ki67 expression is an accurate measure of T cell
proliferation as only cells that have completed cycling display a
decrease in OG ﬂuorescence intensity. Limitations of many
protein reactive dye compounds include cellular toxicity
(Last'ovicka et al., 2009; Shedlock et al., 2010) and sensitivity
to pH and light (Wallace et al., 2008). The Ki67 proliferation
assay requires no incubation orwashing stepsprior to or during
the culture, and exposure of cells to toxic compounds is
eliminated. Additionally, since labelling of cells is not required
before antigen stimulation, detection of Ki67 byﬂowcytometry
can be performed on antigen-stimulated cells after cryopres-
ervation. A limitation of Ki67 as a proliferation marker is its
inability to resolve the number of proliferation cycles that cells
have undergone, as can be done with dye dilution assays
(Parish, 1999; Lyons and Doherty, 2004). Enumeration of cell
cycles enables calculation of the original precursor frequency of
speciﬁc cells, since the number of cells and their respective
number of divisions are known (Givan et al., 1999).
Monitoring vaccine-induced T cell proliferative potential is
important for determining vaccine take, memory function and
long-term persistence of vaccine-speciﬁc responses. Previous
studies have quantiﬁed Ki67 expression directly ex vivo as a
measure of the vaccine-induced proliferative response (Miller
et al., 2008), or in combination with activation markers to
identify antigen-speciﬁc T cells (Stubbe et al., 2006). To detect
increases in the expression of Ki67, these studies relied on low-
level Ki67 expression before vaccination in healthy adults.
Direct ex vivodetection of antigen-speciﬁc Ki67 expressionmay
thus be challenging in individuals with high levels of in vivo T
cell proliferation — such as those resulting from recent
vaccinations or infections. We observed high ex vivo frequen-
cies of Ki67+ CD4+ T cells in toddlers, suggesting elevated
levels of in vivo T cell turnover. This turnover is likely to be
Fig. 4. Cytokine expression proﬁles of proliferating CD4+ T cells. Whole blood or PBMC were cultured for 6 days with no antigen or PPD. On day 6, cells were
restimulated with PMA and ionomycin for 4 h in the presence of Brefeldin A to detect cytokine expression by proliferating T cells. Representative dotplots of
the cytokine expression proﬁles of (A) Ki67+ or BrdU+ CD4+ T cells and (C) Ki67+ or OGlow CD4+ T cells. (B) Proportions of BrdU+, Ki67+ or Ki67+ BrdU−
CD4+ T cells expressing IFN-γ, IL-2 or TNF-α (n=15). (D) Proportions of Ki67+ or OGlow CD4+ T cells expressing IFN-γ, IL-2 or TNF-α (n=14).
48 A. Soares et al. / Journal of Immunological Methods 362 (2010) 43–50driven by routine childhood vaccinations and exposure to
infections, common in this age group. Whole blood cultured in
the absence of antigen reduced Ki67 expression to barelyTable 1
Intra-assay CV values for T cell frequencies of Ki67 expression after PPD or PHA sti
Subset Donor 1 Donor 2
Ki67+ CD4+ Ki67+ CD8+ Ki67+ CD4+
PPD stimulation
Mean 66.2 10.31 79.82
SD 1.88 1.66 1.46
CV 2.84 16.14 1.83
PHA stimulation
Mean 94.5 91.26 94.7
SD 0.87 1.14 0.81
CV 0.92 1.25 0.86detectable levels byday6, presumably due to cells reverting to a
quiescent state. Therefore, this 6-day assay proved to be
sufﬁciently speciﬁc and sensitive for the identiﬁcation of rare,mulation.
Donor 3
Ki67+ CD8+ Ki67+ CD4+ Ki67+ CD8+
8.3 62.79 3.03
0.86 1.33 0.34
10.42 2.12 11.17
91.7 76.65 74.54
1.11 3.32 2.4
1.21 4.33 3.21
Fig. 5.Monitoring of vaccine-induced T cell proliferation. (A) Dotplots showing Ki67 expression by CD4+ T cells from a representative 18 month old toddler before
(pre-TT) and after TT vaccination (post-TT). Dotplots are gated on live, CD3+ lymphocytes. Values in each dotplot represent the frequency of Ki67+ T cells within
the CD3+ CD8− T cell population. Frequencies of (B) TT-speciﬁc and (C) BCG-speciﬁc CD4+ T cells pre- and post-TT vaccination in 11 toddlers. CD4+ T cells are
deﬁned as CD3+ CD8− T cells (see Data analysis). (D) Relative increase in TT-speciﬁc or BCG-speciﬁc CD4+ T cells pre- and post-TT. The lines represent the
medians. (E) Dotplots depicting frequencies of Ki67+ CD4+ T cells in whole blood directly ex vivo or after culture in the absence of antigen (unstim.) for 6 days.
Values in each dotplot represent the frequency of Ki67+ T cells within the CD3+ CD8− T cell population. (F) Frequencies of Ki67+ CD4+ T cells directly ex vivo or
after culture for 6 days with medium (n=11). CD4+ T cells are deﬁned as CD3+ CD8− T cells (see Data analysis). Differences were calculated using theWilcoxon
matched pairs test.
49A. Soares et al. / Journal of Immunological Methods 362 (2010) 43–50antigen-speciﬁc T cells following vaccination in the context of
high ex vivo frequencies of Ki67+ T cells.
Overall, our data show that outcomes of the Ki67 assay
correlate strongly with current ﬂow cytometry based whole
blood and PBMC proliferation assays. This assay is highly
reproducible, versatile, and presents several practical
advantages over current techniques. We propose Ki67 as a
marker for quantifying antigen-speciﬁc T cell proliferation,and utilising this assay to monitor T cell responses in large
ﬁeld studies or paediatric studies based on limited blood
volumes.
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